Evaluation of HPV infection and presence of licensed HPV vaccine genotypes among genital warts in Foshan, China

ObjectiveThis study aimed to evaluate the prevalence of human papillomavirus (HPV) infection and presence of licensed HPV vaccine genotypes among patients with genital warts in Foshan, China from 2015 to 2022, to provide useful references for the detection, prevention and control of genital warts in...

Full description

Bibliographic Details
Main Authors: Zeqi Huang, Shaonuan Yao, Lin Zou, Weixian Xie, Dongde Xie, Weiwei Li, Deyou Tan, Jiangang Shuai
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-04-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2024.1376141/full
_version_ 1797203143983890432
author Zeqi Huang
Shaonuan Yao
Lin Zou
Weixian Xie
Dongde Xie
Weiwei Li
Deyou Tan
Jiangang Shuai
author_facet Zeqi Huang
Shaonuan Yao
Lin Zou
Weixian Xie
Dongde Xie
Weiwei Li
Deyou Tan
Jiangang Shuai
author_sort Zeqi Huang
collection DOAJ
description ObjectiveThis study aimed to evaluate the prevalence of human papillomavirus (HPV) infection and presence of licensed HPV vaccine genotypes among patients with genital warts in Foshan, China from 2015 to 2022, to provide useful references for the detection, prevention and control of genital warts in Foshan.MethodsThe present study retrospectively analyzed the HPV detection rates in patients with genital warts. A total of 1,625 patients were seen at the Second People’s Hospital of Foshan, Guangdong Province, China, from 2015 to 2022. Samples were collected from various lesions and genotyped for 21 genotypes of HPV by infusion hybridization. The classification principle of HPV genotypes in this study: (1) Based on the relationship between HPV and carcinogenicity; (2) Based on the number of HPV genotypes infected; (3) Based on the HPV genotypes of licensed HPV vaccines.ResultsThe detection rate of any HPV in patients with genital warts was 80.37% (1,306/1,625). The detection rates of HPV for low-risk infection, co-infection and high-risk infection were 49.48% (804/1,625), 24.92% (405/1,625) and 5.97% (97/1,625), respectively. Single infection was the predominant type (51.94%, 844/1625). HPV-6 and HPV-11 were the predominant types of single infection; HPV-6 and HPV-52 were the predominant types of paired combinations of multiple infection. 82.22% (1,336/1,625) of the cases had an age distribution of ≤ 24, 25–34, and 35–44. The distribution of some HPV genotypes had age specificity, annual specificity and gender specificity. The genotype detection rates of 2v, 4v and 9v showed a decreasing trend with ages (all P < 0.05). The genotype detection rates of 4v and 9v showed a decreasing trend over the 8-year period (both P < 0.05). The genotype detection rates of 4v and 9v in the male group were higher than those in the female group (both P < 0.05). The genotype detection rate of 9v was significantly higher than that of 2v and 4v in the female group (both P < 0.05).ConclusionOur study demonstrated that low-risk infection and single infection were the main types of HPV infection in patients with genital warts, mainly among young patients. Our study provides epidemiological data for the detection, prevention and control of genital warts in China.
first_indexed 2024-04-24T08:14:39Z
format Article
id doaj.art-1decff77325a4372afe064774228d1eb
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-04-24T08:14:39Z
publishDate 2024-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-1decff77325a4372afe064774228d1eb2024-04-17T04:16:39ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2024-04-011510.3389/fmicb.2024.13761411376141Evaluation of HPV infection and presence of licensed HPV vaccine genotypes among genital warts in Foshan, ChinaZeqi Huang0Shaonuan Yao1Lin Zou2Weixian Xie3Dongde Xie4Weiwei Li5Deyou Tan6Jiangang Shuai7Department of Clinical Laboratory, The Second People’s Hospital of Foshan, Foshan, ChinaDepartment of Medical Records, The Second People’s Hospital of Foshan, Foshan, ChinaDepartment of Clinical Laboratory, The Second People’s Hospital of Foshan, Foshan, ChinaDepartment of Clinical Laboratory, The Second People’s Hospital of Foshan, Foshan, ChinaDepartment of Clinical Laboratory, The Second People’s Hospital of Foshan, Foshan, ChinaDepartment of Clinical Laboratory, The Second People’s Hospital of Foshan, Foshan, ChinaDepartment of Dermatology, The Second People’s Hospital of Foshan, Foshan, ChinaDepartment of Gynaecology, The Second People’s Hospital of Foshan, Foshan, ChinaObjectiveThis study aimed to evaluate the prevalence of human papillomavirus (HPV) infection and presence of licensed HPV vaccine genotypes among patients with genital warts in Foshan, China from 2015 to 2022, to provide useful references for the detection, prevention and control of genital warts in Foshan.MethodsThe present study retrospectively analyzed the HPV detection rates in patients with genital warts. A total of 1,625 patients were seen at the Second People’s Hospital of Foshan, Guangdong Province, China, from 2015 to 2022. Samples were collected from various lesions and genotyped for 21 genotypes of HPV by infusion hybridization. The classification principle of HPV genotypes in this study: (1) Based on the relationship between HPV and carcinogenicity; (2) Based on the number of HPV genotypes infected; (3) Based on the HPV genotypes of licensed HPV vaccines.ResultsThe detection rate of any HPV in patients with genital warts was 80.37% (1,306/1,625). The detection rates of HPV for low-risk infection, co-infection and high-risk infection were 49.48% (804/1,625), 24.92% (405/1,625) and 5.97% (97/1,625), respectively. Single infection was the predominant type (51.94%, 844/1625). HPV-6 and HPV-11 were the predominant types of single infection; HPV-6 and HPV-52 were the predominant types of paired combinations of multiple infection. 82.22% (1,336/1,625) of the cases had an age distribution of ≤ 24, 25–34, and 35–44. The distribution of some HPV genotypes had age specificity, annual specificity and gender specificity. The genotype detection rates of 2v, 4v and 9v showed a decreasing trend with ages (all P < 0.05). The genotype detection rates of 4v and 9v showed a decreasing trend over the 8-year period (both P < 0.05). The genotype detection rates of 4v and 9v in the male group were higher than those in the female group (both P < 0.05). The genotype detection rate of 9v was significantly higher than that of 2v and 4v in the female group (both P < 0.05).ConclusionOur study demonstrated that low-risk infection and single infection were the main types of HPV infection in patients with genital warts, mainly among young patients. Our study provides epidemiological data for the detection, prevention and control of genital warts in China.https://www.frontiersin.org/articles/10.3389/fmicb.2024.1376141/fullhuman papillomavirusinfectionHPV vaccinegenotypegenital warts
spellingShingle Zeqi Huang
Shaonuan Yao
Lin Zou
Weixian Xie
Dongde Xie
Weiwei Li
Deyou Tan
Jiangang Shuai
Evaluation of HPV infection and presence of licensed HPV vaccine genotypes among genital warts in Foshan, China
Frontiers in Microbiology
human papillomavirus
infection
HPV vaccine
genotype
genital warts
title Evaluation of HPV infection and presence of licensed HPV vaccine genotypes among genital warts in Foshan, China
title_full Evaluation of HPV infection and presence of licensed HPV vaccine genotypes among genital warts in Foshan, China
title_fullStr Evaluation of HPV infection and presence of licensed HPV vaccine genotypes among genital warts in Foshan, China
title_full_unstemmed Evaluation of HPV infection and presence of licensed HPV vaccine genotypes among genital warts in Foshan, China
title_short Evaluation of HPV infection and presence of licensed HPV vaccine genotypes among genital warts in Foshan, China
title_sort evaluation of hpv infection and presence of licensed hpv vaccine genotypes among genital warts in foshan china
topic human papillomavirus
infection
HPV vaccine
genotype
genital warts
url https://www.frontiersin.org/articles/10.3389/fmicb.2024.1376141/full
work_keys_str_mv AT zeqihuang evaluationofhpvinfectionandpresenceoflicensedhpvvaccinegenotypesamonggenitalwartsinfoshanchina
AT shaonuanyao evaluationofhpvinfectionandpresenceoflicensedhpvvaccinegenotypesamonggenitalwartsinfoshanchina
AT linzou evaluationofhpvinfectionandpresenceoflicensedhpvvaccinegenotypesamonggenitalwartsinfoshanchina
AT weixianxie evaluationofhpvinfectionandpresenceoflicensedhpvvaccinegenotypesamonggenitalwartsinfoshanchina
AT dongdexie evaluationofhpvinfectionandpresenceoflicensedhpvvaccinegenotypesamonggenitalwartsinfoshanchina
AT weiweili evaluationofhpvinfectionandpresenceoflicensedhpvvaccinegenotypesamonggenitalwartsinfoshanchina
AT deyoutan evaluationofhpvinfectionandpresenceoflicensedhpvvaccinegenotypesamonggenitalwartsinfoshanchina
AT jiangangshuai evaluationofhpvinfectionandpresenceoflicensedhpvvaccinegenotypesamonggenitalwartsinfoshanchina